Evaluation of the efficacy and safety of vilazodone for treating major depressive disorder

PURPOSE: Vilazodone is a novel serotonin (5-HT)-reuptake inhibitor and 5-HT(1A) partial agonist that was recently developed for the treatment of major depressive disorder (MDD). We conducted a meta-analysis and systematic review to better evaluate the efficacy and safety of vilazodone. MATERIALS AND...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xiao-Fei, Wu, Lei, Wan, Dong-Jun, Liu, Ruo-Zhuo, Dong, Zhao, Chen, Min, Yu, Sheng-Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4531002/
https://www.ncbi.nlm.nih.gov/pubmed/26345981
http://dx.doi.org/10.2147/NDT.S87968

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4531002/
https://www.ncbi.nlm.nih.gov/pubmed/26345981
http://dx.doi.org/10.2147/NDT.S87968

Ejemplares similares